Affiliate content. See how LeanBliss and SuperThin stack up against each other when it comes to weight loss support.

A recent study highlights alarming health statistics among doctors in Gujarat, revealing that 20% are obese, 53% diabetic, and 24% hypertensive, raising concerns about their own health amid advocacy ...

The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to ...

The FDA says the shortage of tirzepatide injection — a glucagon-like peptide 1 medication used for diabetes and weight loss — ...

The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

Excess weight can lead to a host of issues, including heart disease, diabetes, and decreased quality ... as two contenders that claim to support weight loss effectively. But how do these ...

With the most potent weight-loss shot and a pipeline of 11 experimental ... down the rights to license a promising GLP-1 pill to treat type 2 diabetes from its sister company Chugai, a rivalry ...

If you’re living with diabetes, learn why you may be at greater risk for opioid use (and misuse) and what to do about it.

Researchers at Aarhus University have synthesized a molecule called LaKe that replicates the metabolic effects of exercise ...

The Danish drugmaker reported last year that a late-stage study in people who don’t have diabetes showed that the daily pill led to an average weight loss of 15% over 68 weeks, a similar result ...